http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003225032-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
filingDate 2002-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8934a501fc6ab95b8ba724b5e2f7f4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273744fe59a601e8a314e0dc482c3fcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_984c2174df581c9c11ba9287730d55ea
publicationDate 2003-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2003225032-A1
titleOfInvention Pharmaceutical composition
abstract The present invention provides a pharmaceutical composition comprising N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and sulfobutyl ether β-cyclodextrin or a salt thereof, wherein sulfobutyl ether β-cyclodextrin increases the solubility of N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformamidine and improves the photostability.
priorityDate 2002-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229208702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87089905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226646046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128775069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127675582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12856218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68536128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18539871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423313

Total number of triples: 43.